176 related articles for article (PubMed ID: 37373167)
21. Preoperative Clinical and Sonographic Predictors for Lateral Cervical Lymph Node Metastases in Sporadic Medullary Thyroid Carcinoma.
Oh HS; Kwon H; Song E; Jeon MJ; Song DE; Kim TY; Lee JH; Hong SJ; Kim WB; Shong YK; Baek JH; Kim WG
Thyroid; 2018 Mar; 28(3):362-368. PubMed ID: 29350102
[TBL] [Abstract][Full Text] [Related]
22. Combining serum calcitonin, carcinoembryonic antigen, and neuron-specific enolase to predict lateral lymph node metastasis in medullary thyroid carcinoma.
Ye L; Zhou X; Lu J; Wang Y; Xie X; Zhang J
J Clin Lab Anal; 2020 Jul; 34(7):e23278. PubMed ID: 32141647
[TBL] [Abstract][Full Text] [Related]
23. Leflunomide suppresses growth in human medullary thyroid cancer cells.
Alhefdhi A; Burke JF; Redlich A; Kunnimalaiyaan M; Chen H
J Surg Res; 2013 Nov; 185(1):212-6. PubMed ID: 23816245
[TBL] [Abstract][Full Text] [Related]
24. Unilateral Surgery for Medullary Thyroid Carcinoma: Seeking for Clinical Practice Guidelines.
Zhang D; Colombo C; Sun H; Kim HY; Pino A; De Leo S; Gazzano G; Persani L; Dionigi G; Fugazzola L
Front Endocrinol (Lausanne); 2022; 13():875875. PubMed ID: 35898450
[TBL] [Abstract][Full Text] [Related]
25. An Undetectable Postoperative Calcitonin Level Is Associated with Long-Term Disease-Free Survival in Medullary Thyroid Carcinoma: Results of a Retrospective Cohort Study.
Duval MADS; Ferreira CV; Marmitt L; Dora JM; Espíndola M; Benini AF; Camelier MV; Bulzico D; Andrade FA; Alves Júnior PA; Corbo R; Vaisman F; Zanella AB; Scheffel RS; Maia AL
Thyroid; 2023 Jan; 33(1):82-90. PubMed ID: 36222615
[No Abstract] [Full Text] [Related]
26. PD-1/PD-L1 expressions in medullary thyroid carcinoma: Clinicopathologic and prognostic analysis of Chinese population.
Bi Y; Ren X; Bai X; Meng Y; Luo Y; Cao J; Zhang Y; Liang Z
Eur J Surg Oncol; 2019 Mar; 45(3):353-358. PubMed ID: 30528043
[TBL] [Abstract][Full Text] [Related]
27. Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging.
Smith A; Galli M; Piga I; Denti V; Stella M; Chinello C; Fusco N; Leni D; Manzoni M; Roversi G; Garancini M; Pincelli AI; Cimino V; Capitoli G; Magni F; Pagni F
J Proteomics; 2019 Jan; 191():114-123. PubMed ID: 29581064
[TBL] [Abstract][Full Text] [Related]
28. T Cells Engineered to Express Immunoreceptors Targeting the Frequently Expressed Medullary Thyroid Cancer Antigens Calcitonin, CEA, and RET M918T.
Erickson TA; Shih YP; Fass J; Jang M; Tran E
Thyroid; 2022 Jul; 32(7):789-798. PubMed ID: 35587601
[No Abstract] [Full Text] [Related]
29. SSTR2A expression in medullary thyroid carcinoma is correlated with longer survival.
de Vries LH; Lodewijk L; Willems SM; Dreijerink KMA; de Keizer B; van Diest PJ; Schepers A; Bonenkamp HJ; van Engen-van Grunsven IACH; Kruijff S; van Hemel BM; Links TP; Nieveen van Dijkum EJM; van Eeden S; Valk GD; Borel Rinkes IHM; Vriens MR
Endocrine; 2018 Dec; 62(3):639-647. PubMed ID: 30128959
[TBL] [Abstract][Full Text] [Related]
30. [Correlation analysis of clock genes and MEN2 medullary thyroid carcinoma].
Mou YK; Ren C; Li YM; Yu GH; Zheng GB; Song H; Lu CX; Tian RX; Song XC
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Sep; 57(9):1079-1086. PubMed ID: 36177562
[No Abstract] [Full Text] [Related]
31. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
[TBL] [Abstract][Full Text] [Related]
32. Calcitonin receptor mRNA is expressed in human medullary thyroid carcinoma.
Frendo JL; Delage-Mourroux R; Cohen R; Pichaud F; Pidoux E; Guliana JM; Jullienne A
Thyroid; 1998 Feb; 8(2):141-7. PubMed ID: 9510122
[TBL] [Abstract][Full Text] [Related]
33. Current understanding and management of medullary thyroid cancer.
Roy M; Chen H; Sippel RS
Oncologist; 2013; 18(10):1093-100. PubMed ID: 24037980
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis, treatment, and follow-up of medullary thyroid carcinoma: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism.
Maia AL; Siqueira DR; Kulcsar MA; Tincani AJ; Mazeto GM; Maciel LM
Arq Bras Endocrinol Metabol; 2014 Oct; 58(7):667-700. PubMed ID: 25372577
[TBL] [Abstract][Full Text] [Related]
35. Medullary thyroid carcinoma: management of lymph node metastases.
Quayle FJ; Moley JF
Curr Treat Options Oncol; 2005 Jul; 6(4):347-54. PubMed ID: 15967087
[TBL] [Abstract][Full Text] [Related]
36. Integrated analysis of transcription factor-mRNA-miRNA regulatory network related to immune characteristics in medullary thyroid carcinoma.
Weng D; He L; Chen X; Lin H; Ji D; Lu S; Ao L; Wang S
Front Immunol; 2022; 13():1055412. PubMed ID: 36713370
[TBL] [Abstract][Full Text] [Related]
37. Medullary thyroid carcinoma beyond surgery: advances, challenges, and perspectives.
Ceolin L; Duval MADS; Benini AF; Ferreira CV; Maia AL
Endocr Relat Cancer; 2019 Aug; 26(9):R499-R518. PubMed ID: 31252403
[TBL] [Abstract][Full Text] [Related]
38. RT-PCR-based detection of circulating calcitonin-producing cells in patients with advanced medullary thyroid cancer.
Saller B; Feldmann G; Haupt K; Broecker M; Janssen OE; Roggendorf M; Mann K; Lu M
J Clin Endocrinol Metab; 2002 Jan; 87(1):292-6. PubMed ID: 11788662
[TBL] [Abstract][Full Text] [Related]
39. Tumor protein p53-induced nuclear protein (TP53INP1) expression in medullary thyroid carcinoma: a molecular guide to the optimal extent of surgery?
Taïeb D; Giusiano S; Sebag F; Marcy M; de Micco C; Palazzo FF; Dusetti NJ; Iovanna JL; Henry JF; Garcia S; Taranger-Charpin C
World J Surg; 2010 Apr; 34(4):830-5. PubMed ID: 20145930
[TBL] [Abstract][Full Text] [Related]
40. Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level.
Machens A; Schneyer U; Holzhausen HJ; Dralle H
J Clin Endocrinol Metab; 2005 Apr; 90(4):2029-34. PubMed ID: 15634717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
